HealthEquity Price to Sales Ratio vs Interest Expense Analysis

HQY Stock

USD 79.20 0.67 0.84%

HealthEquity financial indicator trend analysis is much more than just examining HealthEquity latest accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether HealthEquity is a good investment. Please check the relationship between HealthEquity Price To Sales Ratio and its Interest Expense accounts. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in HealthEquity. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in producer price index.

For more information on how to buy HealthEquity Stock please use our How to Invest in HealthEquity guide.

Price To Sales Ratio vs Interest Expense

Price to Sales Ratio vs Interest Expense Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of HealthEquity Price to Sales Ratio account and Interest Expense. At this time, the significance of the direction appears to have weak contrarian relationship.

The correlation between HealthEquity's Price to Sales Ratio and Interest Expense is -0.13. Overlapping area represents the amount of variation of Price to Sales Ratio that can explain the historical movement of Interest Expense in the same time period over historical financial statements of HealthEquity, assuming nothing else is changed. The correlation between historical values of HealthEquity's Price to Sales Ratio and Interest Expense is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Price to Sales Ratio of HealthEquity are associated (or correlated) with its Interest Expense. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Interest Expense has no effect on the direction of Price to Sales Ratio i.e., HealthEquity's Price to Sales Ratio and Interest Expense go up and down completely randomly.

Correlation Coefficient

-0.13

Relationship Direction	Negative
Relationship Strength	Insignificant

View All Relationships

Price To Sales Ratio

Price to Sales Ratio is figured by comparing HealthEquity stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on HealthEquity sales, a figure that is much harder to manipulate than other HealthEquity multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. A valuation ratio that compares a company’s stock price to its revenues, calculated by dividing the company’s market cap by its total sales or revenue over a 12-month period.

Interest Expense

The cost incurred by an entity for borrowed funds, including loans, bonds, or lines of credit.

Most indicators from HealthEquity's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into HealthEquity current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in HealthEquity. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in producer price index.

For more information on how to buy HealthEquity Stock please use our How to Invest in HealthEquity guide.At this time, HealthEquity's Selling General Administrative is fairly stable compared to the past year. Tax Provision is likely to rise to about 20.3 M in 2024, whereas Sales General And Administrative To Revenue is likely to drop 0.08 in 2024.

	2021	2022	2023	2024 (projected)
Gross Profit	423.7M	490.1M	529.9M	556.4M
Total Revenue	756.6M	861.7M	999.6M	1.0B

Gross Profit Total Revenue

HealthEquity fundamental ratios Correlations

	Total Assets	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Other Liab	Accounts Payable	Cash	Other Assets	Good Will	Common Stock Shares Outstanding	Short Term Investments	Inventory	Other Current Assets	Total Liab	Intangible Assets	Common Stock	Property Plant Equipment	Property Plant And Equipment Net	Net Debt	Retained Earnings	Non Current Assets Total	Cash And Short Term Investments	Net Receivables	Common Stock Total Equity	Non Current Liabilities Total	Other Stockholder Equity
Total Assets		0.91	0.89	0.98	0.97	0.67	0.69	0.61	0.99	0.76	0.91	-0.76	0.95	0.91	0.93	0.76	0.92	0.85	0.84	0.83	1.0	0.67	0.94	0.75	0.92	0.97
Other Current Liab	0.91		0.99	0.85	0.95	0.61	0.72	0.76	0.88	0.74	0.85	-0.75	0.92	0.98	0.97	0.77	0.91	0.96	0.9	0.9	0.92	0.68	0.94	0.77	0.97	0.84
Total Current Liabilities	0.89	0.99		0.81	0.94	0.55	0.66	0.78	0.85	0.7	0.82	-0.72	0.9	0.97	0.94	0.72	0.9	0.98	0.92	0.87	0.89	0.62	0.9	0.72	0.96	0.79
Total Stockholder Equity	0.98	0.85	0.81		0.9	0.72	0.72	0.54	0.98	0.77	0.9	-0.73	0.91	0.83	0.89	0.77	0.91	0.74	0.73	0.8	0.97	0.71	0.93	0.76	0.83	1.0
Other Liab	0.97	0.95	0.94	0.9		0.57	0.62	0.63	0.95	0.68	0.87	-0.74	0.96	0.96	0.93	0.7	0.9	0.94	0.92	0.84	0.97	0.59	0.9	0.7	0.96	0.88
Accounts Payable	0.67	0.61	0.55	0.72	0.57		0.43	0.61	0.66	0.59	0.57	-0.48	0.5	0.6	0.74	0.55	0.59	0.48	0.55	0.51	0.69	0.4	0.72	0.56	0.6	0.73
Cash	0.69	0.72	0.66	0.72	0.62	0.43		0.49	0.64	0.77	0.84	-0.65	0.68	0.62	0.65	0.87	0.69	0.58	0.41	0.9	0.64	0.99	0.76	0.87	0.61	0.7
Other Assets	0.61	0.76	0.78	0.54	0.63	0.61	0.49		0.53	0.58	0.62	-0.6	0.51	0.74	0.77	0.57	0.58	0.77	0.71	0.69	0.62	0.44	0.69	0.57	0.72	0.53
Good Will	0.99	0.88	0.85	0.98	0.95	0.66	0.64	0.53		0.72	0.88	-0.74	0.94	0.89	0.91	0.71	0.91	0.81	0.83	0.78	0.99	0.61	0.92	0.7	0.9	0.97
Common Stock Shares Outstanding	0.76	0.74	0.7	0.77	0.68	0.59	0.77	0.58	0.72		0.75	-0.56	0.68	0.7	0.76	0.87	0.7	0.64	0.57	0.78	0.73	0.78	0.81	0.87	0.7	0.76
Short Term Investments	0.91	0.85	0.82	0.9	0.87	0.57	0.84	0.62	0.88	0.75		-0.84	0.87	0.82	0.83	0.78	0.83	0.78	0.69	0.93	0.89	0.82	0.87	0.77	0.82	0.88
Inventory	-0.76	-0.75	-0.72	-0.73	-0.74	-0.48	-0.65	-0.6	-0.74	-0.56	-0.84		-0.74	-0.72	-0.72	-0.44	-0.7	-0.69	-0.63	-0.81	-0.75	-0.6	-0.73	-0.44	-0.72	-0.72
Other Current Assets	0.95	0.92	0.9	0.91	0.96	0.5	0.68	0.51	0.94	0.68	0.87	-0.74		0.88	0.86	0.69	0.97	0.86	0.8	0.81	0.94	0.66	0.87	0.68	0.88	0.9
Total Liab	0.91	0.98	0.97	0.83	0.96	0.6	0.62	0.74	0.89	0.7	0.82	-0.72	0.88		0.97	0.71	0.84	0.96	0.97	0.85	0.92	0.58	0.93	0.71	1.0	0.81
Intangible Assets	0.93	0.97	0.94	0.89	0.93	0.74	0.65	0.77	0.91	0.76	0.83	-0.72	0.86	0.97		0.75	0.87	0.91	0.92	0.84	0.95	0.61	0.98	0.75	0.97	0.88
Common Stock	0.76	0.77	0.72	0.77	0.7	0.55	0.87	0.57	0.71	0.87	0.78	-0.44	0.69	0.71	0.75		0.71	0.67	0.56	0.84	0.73	0.89	0.82	1.0	0.71	0.76
Property Plant Equipment	0.92	0.91	0.9	0.91	0.9	0.59	0.69	0.58	0.91	0.7	0.83	-0.7	0.97	0.84	0.87	0.71		0.83	0.75	0.78	0.91	0.66	0.86	0.7	0.84	0.9
Property Plant And Equipment Net	0.85	0.96	0.98	0.74	0.94	0.48	0.58	0.77	0.81	0.64	0.78	-0.69	0.86	0.96	0.91	0.67	0.83		0.94	0.84	0.86	0.54	0.84	0.67	0.96	0.72
Net Debt	0.84	0.9	0.92	0.73	0.92	0.55	0.41	0.71	0.83	0.57	0.69	-0.63	0.8	0.97	0.92	0.56	0.75	0.94		0.7	0.87	0.36	0.84	0.56	0.97	0.72
Retained Earnings	0.83	0.9	0.87	0.8	0.84	0.51	0.9	0.69	0.78	0.78	0.93	-0.81	0.81	0.85	0.84	0.84	0.78	0.84	0.7		0.81	0.88	0.87	0.84	0.84	0.77
Non Current Assets Total	1.0	0.92	0.89	0.97	0.97	0.69	0.64	0.62	0.99	0.73	0.89	-0.75	0.94	0.92	0.95	0.73	0.91	0.86	0.87	0.81		0.61	0.94	0.72	0.93	0.96
Cash And Short Term Investments	0.67	0.68	0.62	0.71	0.59	0.4	0.99	0.44	0.61	0.78	0.82	-0.6	0.66	0.58	0.61	0.89	0.66	0.54	0.36	0.88	0.61		0.73	0.89	0.57	0.68
Net Receivables	0.94	0.94	0.9	0.93	0.9	0.72	0.76	0.69	0.92	0.81	0.87	-0.73	0.87	0.93	0.98	0.82	0.86	0.84	0.84	0.87	0.94	0.73		0.82	0.94	0.92
Common Stock Total Equity	0.75	0.77	0.72	0.76	0.7	0.56	0.87	0.57	0.7	0.87	0.77	-0.44	0.68	0.71	0.75	1.0	0.7	0.67	0.56	0.84	0.72	0.89	0.82		0.71	0.75
Non Current Liabilities Total	0.92	0.97	0.96	0.83	0.96	0.6	0.61	0.72	0.9	0.7	0.82	-0.72	0.88	1.0	0.97	0.71	0.84	0.96	0.97	0.84	0.93	0.57	0.94	0.71		0.82
Other Stockholder Equity	0.97	0.84	0.79	1.0	0.88	0.73	0.7	0.53	0.97	0.76	0.88	-0.72	0.9	0.81	0.88	0.76	0.9	0.72	0.72	0.77	0.96	0.68	0.92	0.75	0.82

Click cells to compare fundamentals

HealthEquity Account Relationship Matchups

HealthEquity fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	2.6B	2.7B	3.1B	3.1B	3.2B	3.4B
Other Current Liab	96.7M	126.2M	104.7M	89.5M	95.6M	54.8M
Total Current Liabilities	152.1M	204.3M	153.2M	131.1M	117.1M	79.0M
Total Stockholder Equity	1.0B	1.4B	1.9B	1.9B	2.0B	2.1B
Other Liab	133.1M	128.5M	114.0M	95.4M	109.7M	115.2M
Accounts Payable	4.0M	1.6M	27.5M	13.9M	12.0M	6.9M
Cash	191.7M	328.8M	225.4M	254.3M	404.0M	212.6M
Other Assets	35.1M	37.4M	49.8M	52.2M	1.0	0.95
Good Will	1.3B	1.3B	1.6B	1.6B	1.9B	2.0B
Common Stock Shares Outstanding	68.5M	75.7M	83.1M	84.4M	87.0M	68.4M
Other Current Assets	33.8M	58.6M	38.5M	31.8M	48.6M	51.0M
Total Liab	1.5B	1.3B	1.3B	1.2B	1.2B	609.8M
Intangible Assets	783.3M	767.0M	973.1M	936.4M	835.9M	428.2M
Property Plant Equipment	33.5M	118.6M	87.0M	69.3M	79.7M	83.7M
Property Plant And Equipment Net	116.7M	118.6M	87.0M	69.3M	54.4M	47.5M
Net Debt	1.1B	746.2M	782.8M	740.2M	529.2M	299.8M
Retained Earnings	211.5M	220.3M	176.1M	149.9M	205.6M	121.8M
Non Current Assets Total	2.3B	2.2B	2.8B	2.7B	2.7B	2.8B
Cash And Short Term Investments	191.7M	328.8M	225.4M	254.3M	404.0M	243.5M
Net Receivables	70.5M	72.8M	87.4M	96.8M	104.9M	52.6M
Liabilities And Stockholders Equity	2.6B	2.7B	3.1B	3.1B	3.2B	1.6B
Non Current Liabilities Total	1.4B	1.1B	1.1B	1.1B	1.1B	578.7M
Other Stockholder Equity	818.8M	1.2B	1.7B	1.7B	1.8B	1.9B
Property Plant And Equipment Gross	116.7M	118.6M	87.0M	69.3M	95.4M	51.6M
Total Current Assets	296.0M	460.2M	351.3M	382.9M	557.4M	320.0M
Net Tangible Assets	(1.1B)	(715.1M)	(766.4M)	(688.9M)	(620.0M)	(589.0M)
Non Currrent Assets Other	35.1M	37.4M	49.8M	52.2M	(768.1M)	(729.7M)
Retained Earnings Total Equity	85.3M	171.9M	211.5M	220.3M	253.4M	266.1M
Capital Surpluse	261.2M	305.2M	818.8M	1.2B	1.3B	1.4B
Non Current Liabilities Other	1.4B	8.8M	14.2M	12.7M	19.3M	18.3M
Net Invested Capital	2.3B	2.4B	2.8B	2.8B	2.9B	2.2B
Net Working Capital	145.4M	255.5M	198.2M	251.8M	440.3M	298.8M

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect

When determining whether HealthEquity offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of HealthEquity's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Healthequity Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Healthequity Stock:

How To Invest In HealthEquity

Details

Is HealthEquity Stock a good investment?

Details

What is HealthEquity's Net Worth?

Details

Largest Health Care Providers & Services Companies

View

Largest Health Care Equipment & Services Companies

View

Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in HealthEquity. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in producer price index.

For more information on how to buy HealthEquity Stock please use our How to Invest in HealthEquity guide.

You can also try the Top Crypto Exchanges module to search and analyze digital assets across top global cryptocurrency exchanges.

Complementary Tools for HealthEquity Stock analysis

When running HealthEquity's price analysis, check to measure HealthEquity's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy HealthEquity is operating at the current time. Most of HealthEquity's value examination focuses on studying past and present price action to predict the probability of HealthEquity's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move HealthEquity's price. Additionally, you may evaluate how the addition of HealthEquity to your portfolios can decrease your overall portfolio volatility.

	Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities
	Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets
	Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
	Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
	Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
	Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments
	Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets
	Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon
	Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
	Commodity Channel Use Commodity Channel Index to analyze current equity momentum
	AI Investment Finder Use AI to screen and filter profitable investment opportunities
	Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities
	Analyst Advice Analyst recommendations and target price estimates broken down by several categories

Is HealthEquity's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of HealthEquity. If investors know HealthEquity will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about HealthEquity listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

(0.96)

Earnings Share

0.64

Revenue Per Share

11.682

Quarterly Revenue Growth

0.122

Return On Assets

0.0256

The market value of HealthEquity is measured differently than its book value, which is the value of HealthEquity that is recorded on the company's balance sheet. Investors also form their own opinion of HealthEquity's value that differs from its market value or its book value, called intrinsic value, which is HealthEquity's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because HealthEquity's market value can be influenced by many factors that don't directly affect HealthEquity's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between HealthEquity's value and its price as these two are different measures arrived at by different means. Investors typically determine if HealthEquity is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, HealthEquity's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

HealthEquity Price to Sales Ratio vs Interest Expense Analysis

Price To Sales Ratio vs Interest Expense

Price to Sales Ratio vs Interest Expense Correlation Analysis

Correlation Coefficient

Price To Sales Ratio

Interest Expense

HealthEquity fundamental ratios Correlations

HealthEquity Account Relationship Matchups

High Positive Relationship

High Negative Relationship

HealthEquity fundamental ratios Accounts

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

Complementary Tools for HealthEquity Stock analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Non Current Assets Total	+ 1.0	Total Assets
Other Stockholder Equity	+ 1.0	Total Stockholder Equity
Non Current Liabilities Total	+ 1.0	Total Liab
Common Stock Total Equity	+ 1.0	Common Stock
Good Will	+ 0.99	Total Assets
Total Current Liabilities	+ 0.99	Other Current Liab

Inventory	- 0.84	Short Term Investments
Retained Earnings	- 0.81	Inventory
Inventory	- 0.76	Total Assets
Non Current Assets Total	- 0.75	Inventory
Inventory	- 0.75	Other Current Liab
Other Current Assets	- 0.74	Inventory